VivoSim Labs, Inc. (VIVS)
0.2826
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 14:09
VivoSim Labs Market Cap : 0.9027M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.9043M |
| September 10, 2026 | 0.9577M |
| September 09, 2026 | 0.8784M |
| September 08, 2026 | 0.8998M |
| September 04, 2026 | 0.8887M |
| September 03, 2026 | 0.8912M |
| September 02, 2026 | 0.8938M |
| September 01, 2026 | 0.8903M |
| August 31, 2026 | 0.9308M |
| August 28, 2026 | 0.9113M |
| August 27, 2026 | 0.9359M |
| August 26, 2026 | 0.9295M |
| August 25, 2026 | 0.9315M |
| August 24, 2026 | 0.9327M |
| August 21, 2026 | 0.9136M |
| August 20, 2026 | 0.8864M |
| August 19, 2026 | 0.8858M |
| August 18, 2026 | 0.8899M |
| August 17, 2026 | 1.016M |
| August 14, 2026 | 1.030M |
| August 13, 2026 | 1.048M |
| August 12, 2026 | 1.061M |
| August 11, 2026 | 1.126M |
| August 10, 2026 | 1.164M |
| August 07, 2026 | 1.355M |
| Date | Value |
|---|---|
| August 06, 2026 | 0.9549M |
| August 05, 2026 | 1.052M |
| August 04, 2026 | 1.062M |
| August 03, 2026 | 0.9685M |
| July 31, 2026 | 0.9974M |
| July 30, 2026 | 1.117M |
| July 29, 2026 | 0.9983M |
| July 28, 2026 | 1.105M |
| July 27, 2026 | 1.128M |
| July 24, 2026 | 1.212M |
| July 23, 2026 | 1.302M |
| July 22, 2026 | 1.335M |
| July 21, 2026 | 1.302M |
| July 20, 2026 | 1.461M |
| July 17, 2026 | 1.676M |
| July 16, 2026 | 1.776M |
| July 15, 2026 | 2.469M |
| July 14, 2026 | 2.416M |
| July 13, 2026 | 2.341M |
| July 10, 2026 | 2.544M |
| July 09, 2026 | 2.319M |
| July 08, 2026 | 2.042M |
| July 07, 2026 | 2.357M |
| July 06, 2026 | 2.569M |
| July 02, 2026 | 2.556M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 302.57M |
| Amgen, Inc. | 205.03B |
| Anika Therapeutics, Inc. | 283.72M |
| BioCryst Pharmaceuticals, Inc. | 2.086B |
| Imunon, Inc. | 6.999M |
Market Cap Related Metrics
| PS Ratio | 8.241 |
| Price | 0.2826 |
| Earnings Yield | -1.58K% |